{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,2,21]],"date-time":"2025-02-21T05:17:32Z","timestamp":1740115052797,"version":"3.37.3"},"reference-count":10,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2024,5,1]],"date-time":"2024-05-01T00:00:00Z","timestamp":1714521600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,5,1]],"date-time":"2024-05-01T00:00:00Z","timestamp":1714521600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,5,1]],"date-time":"2024-05-01T00:00:00Z","timestamp":1714521600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2024,5,1]],"date-time":"2024-05-01T00:00:00Z","timestamp":1714521600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2024,5,1]],"date-time":"2024-05-01T00:00:00Z","timestamp":1714521600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2024,5,1]],"date-time":"2024-05-01T00:00:00Z","timestamp":1714521600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2024,5,1]],"date-time":"2024-05-01T00:00:00Z","timestamp":1714521600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100014188","name":"Korea Ministry of Science and ICT","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100014188","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003710","name":"Korea Health Industry Development Institute","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100003710","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","clinicalkey.es","clinicalkey.com.au","bmn.com","clinicalkey.com","cell.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Trends in Neurosciences"],"published-print":{"date-parts":[[2024,5]]},"DOI":"10.1016\/j.tins.2024.03.006","type":"journal-article","created":{"date-parts":[[2024,3,28]],"date-time":"2024-03-28T21:09:10Z","timestamp":1711660150000},"page":"324-325","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["CRISPR-based identification of N-terminal acetylation in synucleinopathies"],"prefix":"10.1016","volume":"47","author":[{"given":"Eun-Jin","family":"Bae","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5155-5335","authenticated-orcid":false,"given":"Seung-Jae","family":"Lee","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.tins.2024.03.006_bb0005","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1016\/S1474-4422(19)30287-X","article-title":"The genetic architecture of Parkinson's disease","volume":"19","author":"Blauwendraat","year":"2020","journal-title":"Lancet Neurol."},{"key":"10.1016\/j.tins.2024.03.006_bb0010","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1016\/j.expneurol.2017.10.003","article-title":"Therapeutic approaches to target alpha-synuclein pathology","volume":"298","author":"Brundin","year":"2017","journal-title":"Exp. Neurol."},{"key":"10.1016\/j.tins.2024.03.006_bb0015","article-title":"Sequential CRISPR screening reveals partial NatB inhibition as a strategy to mitigate alpha-synuclein levels in human neurons","volume":"10","author":"Kumar","year":"2024","journal-title":"Sci. Adv."},{"key":"10.1016\/j.tins.2024.03.006_bb0020","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1016\/j.tibs.2020.08.005","article-title":"Protein N-terminal acetylation: structural basis, mechanism, versatility, and regulation","volume":"46","author":"Deng","year":"2021","journal-title":"Trends Biochem. Sci."},{"key":"10.1016\/j.tins.2024.03.006_bb0025","doi-asserted-by":"crossref","first-page":"29739","DOI":"10.1074\/jbc.M600933200","article-title":"Phosphorylation of Ser-129 is the dominant pathological modification of alpha-synuclein in familial and sporadic Lewy body disease","volume":"281","author":"Anderson","year":"2006","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.tins.2024.03.006_bb0030","doi-asserted-by":"crossref","first-page":"601","DOI":"10.1002\/pro.2056","article-title":"N-terminal acetylation is critical for forming alpha-helical oligomer of alpha-synuclein","volume":"21","author":"Trexler","year":"2012","journal-title":"Protein Sci."},{"key":"10.1016\/j.tins.2024.03.006_bb0035","doi-asserted-by":"crossref","first-page":"1743","DOI":"10.1021\/acs.biochem.2c00104","article-title":"N-terminal acetylation of alpha-synuclein slows down its aggregation process and alters the morphology of the resulting aggregates","volume":"61","author":"Bell","year":"2022","journal-title":"Biochemistry"},{"key":"10.1016\/j.tins.2024.03.006_bb0040","doi-asserted-by":"crossref","DOI":"10.1016\/j.jbc.2021.101363","article-title":"N-alpha-acetylation of Huntingtin protein increases its propensity to aggregate","volume":"297","author":"Gottlieb","year":"2021","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.tins.2024.03.006_bb0045","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1186\/s13024-024-00707-x","article-title":"Plasma N-terminal containing tau fragments (NTA-tau): a biomarker of tau deposition in Alzheimer's disease","volume":"19","author":"Lantero-Rodriguez","year":"2024","journal-title":"Mol. Neurodegener."},{"key":"10.1016\/j.tins.2024.03.006_bb0050","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1038\/nrneurol.2013.275","article-title":"Extracellular alpha-synuclein \u2013 a novel and crucial factor in Lewy body diseases","volume":"10","author":"Lee","year":"2014","journal-title":"Nat. Rev. Neurol."}],"container-title":["Trends in Neurosciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0166223624000432?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0166223624000432?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,5,14]],"date-time":"2024-05-14T15:10:14Z","timestamp":1715699414000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0166223624000432"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,5]]},"references-count":10,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2024,5]]}},"alternative-id":["S0166223624000432"],"URL":"https:\/\/doi.org\/10.1016\/j.tins.2024.03.006","relation":{},"ISSN":["0166-2236"],"issn-type":[{"type":"print","value":"0166-2236"}],"subject":[],"published":{"date-parts":[[2024,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"CRISPR-based identification of N-terminal acetylation in synucleinopathies","name":"articletitle","label":"Article Title"},{"value":"Trends in Neurosciences","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.tins.2024.03.006","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}